Business Context and Reporting Period
This Form 6-K filing by NewGenIvf Group Limited covers the month of June 2026, specifically dated June 16, 2026. The Company is a foreign private issuer headquartered in Bangkok, Thailand.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate transaction regarding debt restructuring rather than periodic financial performance results.
Material Changes
On June 16, 2026, the Company entered into a Repurchase and Forbearance Agreement with JAK Opportunities VI LLC. Under this agreement:
- The Company agreed to repurchase certain outstanding convertible notes and warrants previously issued to the Investor.
- The Company agreed to make certain forbearance payments payable in scheduled installments.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or a discussion of general risks. The primary contingency noted is the execution of the Repurchase and Forbearance Agreement, the full terms of which are detailed in Exhibit 10.1.
Investor Verification Checklist
- Verify the specific principal amounts of the convertible notes and warrants to be repurchased.
- Review the schedule and total value of the forbearance payments in Exhibit 10.1.
- Confirm the impact of this agreement on the Company's current debt load and cash flow obligations.
- Examine the press release (Exhibit 99.1) for additional context on the negotiation with JAK Opportunities VI LLC.